Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2176 to 2190 of 7707 results

  1. RenalGuard Therapy for reduction in the incidence of Contrast-Associated AKI (CA-AKI) in at-risk patients

    Register an interest in this interventional procedure   ...

  2. Tucatinib with trastuzumab and pertuzumab for maintenance treatment of HER2-positive unresectable advanced breast cancer after induction chemotherapy [ID6402]

    Awaiting development [GID-TA11487] Expected publication date: TBC

  3. Toripalimab with chemotherapy for untreated recurrent or metastatic nasopharyngeal cancer [ID6406]

    Awaiting development [GID-TA11341] Expected publication date: TBC

  4. Ensitrelvir for treating COVID-19 [ID6231]

    Awaiting development [GID-TA11224] Expected publication date: TBC

  5. Ruxolitinib for treating acute graft-versus-host disease after allogeneic stem cell transplant in people 28 days to 17 years [ID6410]

    Awaiting development [GID-TA11494] Expected publication date: TBC

  6. Cor-Knot for tying suture knots in valve surgery

      Status ...

  7. TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation

      Status ...

  8. Cytokine adsorption technologies for treating respiratory failure in people with COVID-19

      Status ...

  9. Archimedes for biopsy of suspected lung cancer

      Status ...

  10. Actim Pancreatitis for diagnosing acute pancreatitis

      Status ...

  11. CFHealthHub for managing cystic fibrosis during the COVID-19 pandemic

      Status ...

  12. PCONUS2 Bifurcation Aneurysm Implant for complex intracranial aneurysms

      Status ...

  13. Spartan RX point-of-care CYP2C19 test

      Status ...

  14. Healthy.io test for home testing of urine albumin to creatinine ratio

      Status ...